With 9.6 % CAGR, Facial Injectables Market Size worth USD 9.07 billion by 2028

According to Fortune Business Insights, the global Facial Injectables Market size is projected to reach USD 9.07 billion by 2028, at CAGR of 9.6% during forecast period; Increasing Aesthetic Plastic Surgery to Bolster Business in North America

Pune, India, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The global facial injectables market size is expected to reach USD 9.07 billion by 2028, exhibiting a CAGR of 9.6% during the forecast period. The growing cognizance regarding aesthetic beauty can positively impact the global market growth, states Fortune Business Insights™ in a report titled “Facial Injectables Market, 2021-2028.” The market size stood at USD 4.46 billion in 2020.

Key Development:

October 2020: Luminera, a privately-held aesthetics business located in Israel with a portfolio and pipeline of dermal filler treatments, was acquired by Allergan Aesthetics, a division of AbbVie, Inc.


Request a Sample Copy of the Research Report
https://www.fortunebusinessinsights.com/enquiry/sample/facial-injectables-market-100603



Report Scope

Report Coverage

Details

Forecast Period

2021 to 2028

Forecast Period 2021 to 2028 CAGR

9.6%

2028 Value Projection

USD 9.07 Billion

Base Year

2020

Market Size in 2021

USD 4.77 Billion

Historical Data for

2017 to 2019

No. of Pages

144

Key Market Players

ALLERGAN (AbbVie, Inc.) (North Chicago, U.S.), Ipsen Pharma (Paris, France), USWM, LLC (US WorldMeds) (Louisville, U.S.), Revance Therapeutics, Inc. (Nashville, U.S.), Merz Pharma (Frankfurt, Germany), GALDERMA (Lausanne, Switzerland)

Growth Drivers

Rising Number of Nonsurgical Injectable Treatments to Strengthen Growth

Increasing Aesthetic Plastic Surgery to Bolster Business in North America

Increasing Number of Botulinum Toxin and Dermal Fillers Treatments to Enable Expansion


Driving Factor:

 Rising Number of Nonsurgical Injectable Treatments to Strengthen Growth

Aesthetic treatments have become more popular among people of all ages, including children and the elderly. Additionally, the increased safety features of these devices have led to their increased popularity. Therefore, boosting the facial injectables market share. According to the International Society of Aesthetic Plastic Surgery (ISAPS) figures, the total number of nonsurgical injectable treatments performed in India in 2019 was 113,616. Furthermore, nations such as the United States, France, Italy, and Germany saw significant increases in the number of face injectable treatments. According to the American Academy of Face Plastic and Reconstructive Surgery's (AAFPRS) annual study, botulinum toxin and dermal fillers accounted for four-fifth of all treatments performed by facial surgeons in the United States in 2018.